Olferatx
1 known investors
Find your way into Olferatx
Sign up to see every warm intro you have to Olferatx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Olferatx team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Olfera develops biopharmaceutical treatments for neurological conditions that use the olfactory system as a non-invasive pathway to the brain, bypassing the blood-brain barrier. Its platform is used to discover, optimize, and deliver drugs, converting existing FDA-approved and candidate neurological drugs into easier-to-administer therapies.
Investors · 1
E2MC Ventureslisted by E2MC VenturesOrlando · $250K – $2M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Olferatx do?
- Olfera develops biopharmaceutical treatments for neurological conditions that use the olfactory system as a non-invasive pathway to the brain, bypassing the blood-brain barrier. Its platform is used to discover, optimize, and deliver drugs, converting existing FDA-approved and candidate neurological drugs into easier-to-administer therapies.
- Who are Olferatx's investors?
- Olferatx's investors include E2MC Ventures.

